Indo Amines Limited's Subsidiary Indo Speciality Chemicals Becomes Associate Company Following Rights Issue Dilution

1 min read     Updated on 31 Mar 2026, 02:04 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Indo Amines Limited announced that Indo Speciality Chemicals Private Limited has transitioned from subsidiary to associate company status after a rights issue dilution on March 30, 2026. The company's shareholding decreased from 51.39% to 39.39% while maintaining 172,140 shares, as Indo Amines chose not to participate in the rights offering. Management stated the change has limited impact with no material effect on overall operations.

powered bylight_fuzz_icon
36448446

*this image is generated using AI for illustrative purposes only.

Indo amines Limited has informed stock exchanges about a significant change in its corporate structure, with subsidiary Indo Speciality Chemicals Private Limited transitioning to associate company status following a rights issue dilution. The change occurred on March 30, 2026, after Indo Amines chose not to participate in its subsidiary's rights offering.

Shareholding Structure Changes

The non-participation in the rights issue resulted in a dilution of Indo Amines' stake in Indo Speciality Chemicals, though the absolute number of shares remained unchanged. The company provided detailed information about the ownership transition:

Parameter Pre-Rights Issue Post-Rights Issue
Number of Shares Held 172,140 172,140
Shareholding Percentage 51.39% 39.39%
Company Status Subsidiary Associate Company

Regulatory Compliance Details

In compliance with Regulation 30 of SEBI LODR requirements, Indo Amines disclosed comprehensive details of the transaction. The company clarified that no consideration was received as part of this change, and no acquisition cost was involved since the dilution occurred through non-participation rather than active divestment.

Impact Assessment

The management emphasized that the impact of this structural change remains limited in scope. Key aspects of the transition include:

  • Operational Impact: No material effect on overall company operations
  • Financial Consideration: No monetary transaction involved
  • Strategic Influence: Continued significant influence despite reduced ownership
  • Classification Change: Formal reclassification from subsidiary to associate company status

Corporate Governance Implications

The change represents a shift in corporate governance structure while maintaining business relationships. Despite the reduced shareholding percentage, Indo Amines retains substantial influence in Indo Speciality Chemicals through its 39.39% stake. This transition reflects the company's strategic approach to capital allocation and subsidiary management.

The announcement was signed by Company Secretary and Compliance Officer Tripti Sawant, ensuring proper regulatory disclosure and maintaining transparency with stakeholders regarding this corporate restructuring development.

Historical Stock Returns for Indo Amines

1 Day5 Days1 Month6 Months1 Year5 Years
+2.85%+5.19%-10.57%-30.26%-18.96%-14.59%

Will Indo Amines consider participating in future rights issues of Indo Speciality Chemicals to regain majority control?

How might this ownership dilution affect Indo Amines' consolidated financial reporting and revenue recognition going forward?

What strategic factors led Indo Amines to forego the rights issue participation despite losing subsidiary control?

Indo Amines Limited Announces Q3FY26 Results Under Regulation 33 with 4.8% Revenue Growth

3 min read     Updated on 07 Feb 2026, 02:41 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Indo Amines Limited reported mixed Q3FY26 results with standalone revenue growing 4.8% to ₹26,872.68 lakhs while net profit declined 21.2% to ₹1,286.16 lakhs. The nine-month performance showed resilience with 16.97% profit growth and consolidated operations delivering better results with 7.2% revenue increase and 32.8% nine-month profit growth.

powered bylight_fuzz_icon
31999751

*this image is generated using AI for illustrative purposes only.

Indo Amines Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved these results at their meeting held on February 07, 2026, which commenced at 12:00 P.M. (IST) and concluded at 01:40 P.M. (IST).

Standalone Financial Performance

The company's standalone operations demonstrated steady revenue growth during the quarter. Revenue from operations increased by 4.8% year-on-year, reaching ₹26,872.68 lakhs in Q3FY26 compared to ₹25,644.79 lakhs in Q3FY25. Total revenue, including other income, stood at ₹27,103.97 lakhs for the quarter.

Financial Metric Q3FY26 Q3FY25 Change (%)
Revenue from Operations ₹26,872.68 lakhs ₹25,644.79 lakhs +4.8%
Total Revenue ₹27,103.97 lakhs ₹25,870.45 lakhs +4.8%
Net Profit ₹1,286.16 lakhs ₹1,631.63 lakhs -21.2%
Basic EPS ₹1.76 ₹2.24 -21.4%

Despite revenue growth, net profit for the quarter declined to ₹1,286.16 lakhs from ₹1,631.63 lakhs in Q3FY25, representing a 21.2% decrease. This decline was reflected in the earnings per share, which dropped to ₹1.76 from ₹2.24 in the corresponding quarter last year.

Nine-Month Performance Shows Strength

The nine-month performance painted a more positive picture for the company. For the period ended December 31, 2025, standalone revenue from operations grew to ₹80,688.23 lakhs from ₹77,811.80 lakhs in the previous year, marking a 3.7% increase.

Nine-Month Metrics FY26 (9M) FY25 (9M) Growth (%)
Revenue from Operations ₹80,688.23 lakhs ₹77,811.80 lakhs +3.7%
Net Profit ₹5,897.33 lakhs ₹5,041.80 lakhs +16.97%
Basic EPS ₹8.09 ₹6.91 +17.1%

Net profit for the nine-month period showed robust growth of 16.97%, increasing to ₹5,897.33 lakhs from ₹5,041.80 lakhs in the corresponding period last year. The nine-month earnings per share improved to ₹8.09 from ₹6.91.

Consolidated Results

On a consolidated basis, the company's performance included contributions from its subsidiaries across different geographies. Consolidated revenue from operations for Q3FY26 reached ₹27,742.44 lakhs, representing a 7.2% increase from ₹25,884.48 lakhs in Q3FY25.

Consolidated Metrics Q3FY26 Q3FY25 Change (%)
Revenue from Operations ₹27,742.44 lakhs ₹25,884.48 lakhs +7.2%
Net Profit ₹1,186.70 lakhs ₹1,131.26 lakhs +4.9%
Basic EPS ₹1.62 ₹1.52 +6.6%

Consolidated net profit for the quarter improved to ₹1,186.70 lakhs from ₹1,131.26 lakhs in Q3FY25, showing a 4.9% increase. For the nine-month period, consolidated net profit grew significantly by 32.8% to ₹5,881.88 lakhs from ₹4,430.39 lakhs.

Key Financial Ratios and Regulatory Compliance

The company maintained stable financial ratios during the quarter. The debt-equity ratio stood at 0.82, while the current ratio was 1.26, indicating adequate liquidity. The net profit margin for the standalone business was 4.79% for Q3FY26, compared to 6.35% in Q3FY25.

Key Ratios Q3FY26 Q3FY25
Debt Equity Ratio 0.82 0.84
Current Ratio 1.26 1.29
Net Profit Margin 4.79% 6.35%
Operating Margin 10.26% 8.00%

The results were reviewed by the Audit Committee and approved by the Board of Directors on February 07, 2026. The statutory auditors Kulkarni & Khanolkar Chartered Accountants conducted a limited review of the financial results and expressed an unmodified opinion.

Business Operations and Subsidiaries

Indo Amines Limited operates primarily in the manufacturing of chemicals segment with a diversified geographical presence through its subsidiaries including Indo Amine Americas LLC, Indo Amine (Malaysia) SDN BHD, Indo Amine (Changzhou) Co. Ltd., Indo Amine (Europe) Ltd, and Indo Speciality Chemicals Private Ltd. The consolidated results include contributions from these subsidiaries, with the company maintaining a 52.28% holding in Indo Speciality Chemicals Private Ltd.

Historical Stock Returns for Indo Amines

1 Day5 Days1 Month6 Months1 Year5 Years
+2.85%+5.19%-10.57%-30.26%-18.96%-14.59%

More News on Indo Amines

1 Year Returns:-18.96%